Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Coartem™ (Artemether-lumefantrine combination)
United Therapeutics Europe Ltd
Malaria
1 trial -
Commercial Hylenex® recombinant (hyaluronidase human injection)
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Control: Femoral perineural local anesthetic infusion
Summit Therapeutics
Postoperative Pain Following Knee Arthroplasty
1 trial -
Conventional therapy + S (+)-Ketamine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
S-ketamine
1 trial -
Copper IUD
United Therapeutics Europe Ltd
Mucosal Inflammation
1 trial -
Cosyntropin
United Therapeutics Europe Ltd
Postdural Puncture Headache
1 trial -
CrossBoss Catheter
United Therapeutics Europe Ltd
Arteriosclerosis
1 trial -
Cymbalta 30 mg hard gastro-resistant capsules, Vimpat 50 mg film-coated tablets
Disc Medicine
chemotherapy-induced neuropathic pain
1 trial -
Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy
The University of Hong Kong
Fontan
1 trial -
De-escalated Dual Antiplatelet Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
Depo-Medroxyprogesterone Acetate
United Therapeutics Europe Ltd
HIV
1 trial -
Depofoam bupivacaine
Pacira Ireland Limited
Pain, Postoperative
1 trial -
Desvenlafaxine Succinate
Grace Therapeutics
Vascular Depression
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Overall Survival
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Delirium After Living Donor Renal Transplantation
1 trial -
Dexmedetomidine
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Dexmedetomidine
BioXcel Therapeutics
Schizophrenia Agitation
1 trial -
Drawtex dressing
United Therapeutics Europe Ltd
Pilonidal Disease
1 trial -
Dupilumab
Regeneron UK Limited
Moderate-to-Severe Atopic Dermatitis
2 trials -
ELEVIDYS
Sarepta Therapeutics
Duchenne Muscular Dystrophy
1 trial -
ESTRIOL , ESTRADIOL HEMIHYDRATE, PROMESTRIENE, PROGESTERONE, ESTRADIOL VALERATE
The George Institute
Cervical cancer
1 trial -
ETHINYL ESTRADIOL AND LEVOGESTREL
United Therapeutics Europe Ltd
HIV/AIDS
1 trial -
EXPAREL
Pacira Ireland Limited
Postoperative Pain
2 trials -
EXPAREL and Bupivacaine
Pacira Ireland Limited
Postoperative Pain Management
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources